Nutritional factors and polyamine metabolism in colorectal cancer

Nutrition

Volumn 24, Issue 4, 2008, Pages 382-389

  Linsalata, Michele ^a   Russo, Francesco ^a  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

Author keywords

Colorectal cancer; Flavonoids; Polyamines; Probiotics; Resveratrol

Indexed keywords

EFLORNITHINE; FLAVONOID; POLYAMINE; POLYPHENOL; PROBIOTIC AGENT; PUTRESCINE; RESVERATROL; SPERMINE; SULINDAC;

ANTINEOPLASTIC ACTIVITY; CANCER PREVENTION; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CLINICAL TRIAL; COLORECTAL CANCER; DIETARY INTAKE; DISEASE COURSE; HUMAN; MONOTHERAPY; NONHUMAN; POLYAMINE METABOLISM; PRIORITY JOURNAL; REVIEW;

CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; DIET; DISEASE PROGRESSION; HUMANS; INTESTINAL MUCOSA; NUTRITION PHYSIOLOGY; NUTRITIONAL STATUS; POLYAMINES; RISK FACTORS;

EID: 40149111985     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2007.12.014     Document Type: Review

References (88)

1. Jass J.R., Whitehall V.L., Young J., and Leggett B.A. Emerging concepts in colorectal neoplasia. Gastroenterology 123 (2002) 862-876
2. Gonzalez C.A. The European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 9 (2006) 124-126
3. Kelly K.M., Dickinson S.L., Degraffinreid C.R., Tatum C.M., and Paskett E.D. Colorectal cancer screening in 3 racial groups. Am J Health Behav 31 (2007) 502-513
4. Asano T., and McLeod R.S. Dietary fibre for the prevention of colorectal adenomas and carcinomas. Cochrane Database Syst Rev 2 (2002) CD003430
5. Delmonte P., and Rader J.I. Analysis of isoflavones in foods and dietary supplements. J AOAC Int 89 (2006) 1138-1146
6. Hallmans G., Zhang J.X., Lundin E., Stattin P., Johansson A., Johansson I., et al. Rye, lignans and human health. Proc Nutr Soc 62 (2003) 193-199
7. Touillaud M.S., Thiébaut A.C., Fournier A., Niravong M., Boutron-Ruault M.C., and Clavel-Chapelon F. Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status. J Natl Cancer Inst 99 (2007) 475-486
8. Cotterchio M., Boucher B.A., Manno M., Gallinger S., Okey A., and Harper P. Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J Nutr 136 (2006) 3046-3053
9. Lechner D., Kallay E., and Cross H.S. Phytoestrogens and colorectal cancer prevention. Vitam Horm 70 (2005) 169-198
10. Linsalata M., Messa C., Russo F., Cavallini A., and Di Leo A. Estrogen receptors and polyamine levels in human gastric carcinoma. Scand J Gastroenterol 29 (1994) 67-70
11. Russo F., Linsalata M., Messa C., Cavallini A., Notarnicola M., Guerra V., et al. Polyamines and estrogen receptor concentrations in human colorectal carcinomas. Ital J Gastroenterol 24 (1992) 8-12
12. Di Leo A., Messa C., Russo F., Misciagna G., Guerra V., Taveri R., and Leo S. Prognostic value of cytosolic estrogen receptors in human colorectal carcinoma and surrounding mucosa: preliminary results. Dig Dis Sci 39 (1994) 2038-2042
13. Cross H.S., Kallay E., Lechner D., Gerdenitsch W., Adlercreutz H., and Armbrecht H.J. Phytoestrogens and vitamin D metabolism: a new concept for the prevention and therapy of colorectal, prostate, and mammary carcinomas. J Nutr 134 (2004) 1207S-1212S
14. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 (1997) 218-220
15. Signorelli P., and Ghidoni R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem 16 (2005) 449-466
16. Rush J.W., Quadrilatero J., Levy A.S., and Ford R.J. Chronic resveratrol enhances endothelium-dependent relaxation but does not alter eNOS levels in aorta of spontaneously hypertensive rats. Exp Biol Med (Maywood) 232 (2007) 814-822
17. Aggarwal B.B., Bhardwaj A., Aggarwal R.S., Seeram N.P., Shishodia S., and Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24 (2004) 2783-2840
18. Geier M.S., Butler R.N., and Howarth G.S. Probiotics, prebiotics and synbiotics: a role in chemoprevention for colorectal cancer?. Cancer Biol Ther 5 (2006) 1265-1269
19. Fooks L.J., and Gibson G.R. Probiotics as modulators of the gut flora. Br J Nutr 88 (2002) S39-S49
20. Ishikawa H., Akedo I., Otani T., Suzuki T., Nakamura T., Takeyama I., et al. Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer 116 (2005) 762-767
21. Martin K.R. Targeting apoptosis with dietary bioactive agents. Exp Biol Med (Maywood) 231 (2006) 117-129
22. Nishioka K. Polyamines in cancer: basic mechanisms and clinical approaches (1997), R.G. Landes Company, Georgetown
23. Choen S.S. A guide to polyamines (1998), Oxford University Press, New York
24. Thomas T., and Thomas T.J. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic application. Cell Mol Life Sci 58 (2001) 244-258
25. Rothenburg S., Koch-Nolte F., Rich A., and Haag F. A polymorphic dinucleotide repeat in the rat nucleolin gene forms Z-DNA and inhibits promoter activity. Proc Natl Acad Sci U S A 98 (2001) 8985-8990
26. Shah N., Thomas T.J., Lewis J.S., Klinge C.M., Shirahata A., Gelinas C., and Thomas T. Regulation of estrogenic and nuclear factor kB functions by polyamines and their role in polyamine analog-induced apoptosis of breast cancer cells. Oncogene 20 (2001) 1715-1729
27. Morgan D.M.L. Polyamines, An overview. Mol Biotechnol 11 (1999) 229-250
28. Seiler N. How important is the oxidative degradation of spermine?: Minireview article. Amino Acids 26 (2004) 317-319
29. Moinard C., Cynober L., and de Bandt J.P. Polyamines: metabolism and implications in human diseases. Clin Nutr 24 (2005) 184-197
30. Igarashi K., and Kashiwagri K. Polyamines: mysterious modulators of cellular functions. Biochem Biophys Res Commun 271 (2000) 559-564
31. Wallace H.M., and Caslake R. Polyamines and colon cancer. Eur J Gastroenterol Hepatol 13 (2001) 1033-1039
32. Thomas T., and Thomas T.J. Polyamine metabolism and cancer. J Cell Mol Med 7 (2003) 113-126
33. Seiler N., and Raul F. Polyamines and apoptosis. J Cell Mol Med 9 (2005) 623-642
34. Gerner E.W., and Meyskens F.L. Polyamines and cancer: old molecules, new understanding. Natl Rev Cancer 4 (2004) 781-792
35. Linsalata M., Russo F., Cavallini A., Berloco P., and Di Leo A. Polyamines, diamine oxidase, and ornithine decarboxylase activity in colorectal cancer and in normal surrounding mucosa. Dis Colon Rectum 36 (1993) 662-667
36. Shantz L.M., and Levin V.A. Regulation of ornithine decarboxylase during oncogenic transformation: mechanisms and therapeutic potential. Amino Acids 33 (2007) 213-223
37. Linsalata M., Cavallini A., and Di Leo A. Polyamine oxidase activity and polyamine levels in human colorectal cancer and in normal surrounding mucosa. Anticancer Res 17 (1997) 3757-3760
38. Linsalata M., Giannini R., Notarnicola M., and Cavallini A. Peroxisome proliferator-activated receptor gamma and spermine/spermidine N1-acetyltransferase gene expression are significantly correlated in human colorectal cancer. BMC Cancer 6 (2006) 191-197
39. Erdman S.H., Ignatenko N.A., Powell M.B., Blohm-Mangone K.A., Holubec H., Guillen-Rodriguez J.M., and Gerner E.W. APC-dependent changes in expression of genes influencing polyamine metabolism, and consequences for gastrointestinal carcinogenesis, in the Min mouse. Carcinogenesis 20 (1999) 1709-1713
40. Nilsson J.A., Keller U.B., Baudino T.A., Yang C., Norton S., Old J.A., et al. Targeting ornithine decarboxylase in Myc induced lymphomagenesis prevents tumor formation. Cancer Cell 7 (2005) 433-434
41. Tabib A., and Bachrach U. Role of polyamines in mediating malignant transformation and oncogene expression. Int J Biochem Cell Biol 31 (1999) 1289-1295
42. Linsalata M., Notarnicola M., Caruso M.G., Di Leo A., Guerra V., and Russo F. Polyamine biosynthesis in relation to K-ras and p-53 mutations in colorectal carcinoma. Scand J Gastroenterol 39 (2004) 470-477
43. Notarnicola M., Linsalata M., Caruso M.G., Caruso M.L., Altomare D., Lorusso D., et al. Genetic and biochemical changes in colorectal carcinoma in relation to morphologic characteristics. Oncol Rep 10 (2003) 1987-1991
44. Milovic V., and Turchanova L. Polyamines and colon cancer. Biochem Soc Trans 31 (2003) 381-383
45. Linsalata M., Caruso M.G., Leo S., Guerra V., D'Attoma B., and Di Leo A. Prognostic value of tissue polyamine levels in human colorectal carcinoma. Anticancer Res 22 (2002) 2465-2470
46. Linsalata M., Leo S., Guerra V., and Di Leo A. Erythrocyte polyamines and prognosis in colorectal cancer patients. Anticancer Res 20 (2000) 2113-2118
47. Bachrach U. Polyamines and cancer: minireview article. Amino Acids 26 (2004) 307-309
48. Kawakita M., and Hiramatsu K. Diacetylated derivatives of spermine and spermidine as novel promising tumour markers. J Biochem 139 (2006) 315-322
49. Enjoji M., Nakamuta M., Arimura E., Morizono S., Kuniyoshi M., Fukushima M., et al. Clinical significance of urinary N1, N12-diacetylspermine levels in patients with hepatocellular carcinoma. Int J Biol Markers 19 (2004) 322-327
50. Wallace H.M., and Fraser A.V. Inhibitors of polyamine metabolism: review article. Amino Acids 26 (2004) 353-365
51. Seiler N. Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 1. Selective enzyme inhibitors. Curr Drug Targets 4 (2003) 537-564
52. Cipolla B.G., Havouis R., and Moulinoux J.P. Polyamine contents in current foods: a basis for polyamine reduced diet and study of its long term observance and tolerance in prostate carcinoma patients. Amino Acids 33 (2007) 203-212
53. Wallace H.M., and Niiranen K. Polyamine analogues-an update. Amino Acids 33 (2007) 261-265
54. Abeloff M.D., Rosen S.T., Luk G.D., Baylin S.B., Zeltzman M., and Sjoerdsma A. Phase II trials of -difluoromethylornithine, an inhibitor of polyamine synthesis, in advanced small cell lung cancer and colon cancer. Cancer Treat Rep 70 (1986) 843-845
55. Meyskens Jr. F.L., Gerner E.W., Emerson S., Pelot D., Durbin T., Doyle K., and Lagerberg W. Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention. J Natl Cancer Inst 90 (1998) 1212-1218
56. Lawson K.R., Ignatenko N.A., Piazza G.A., Cui H., and Gerner E.W. Influence of K-ras activation on the survival responses of Caco-2 cells to the chemopreventive agents sulindac and difluoromethylornithine. Cancer Epidemiol Biomark Prev 9 (2000) 1155-1162
57. Lii H., Schut H.A., Conran P., Kramer P.M., Lubet R.A., Steele V.E., et al. Prevention by aspirin and its combination with alpha-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon. Carcinogenesis 20 (1999) 425-430
58. Babbar N., Ignatenko N.A., Casero Jr. R.A., and Gerner E.W. Cyclooxygenase-independent induction of apoptosis by sulindac sulfone is mediated by polyamines in colon cancer. J Biol Chem 278 (2003) 47762-47775
59. Babbar N., Gerner E.W., and Casero Jr. R.J. Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells. Biochem J 394 (2006) 317-324
60. Gerner E.W., Meyskens Jr. F.L., Goldschmid S., Lance P., and Pelot D. Rationale for, and design of, a clinical trial targeting polyamine metabolism for colon cancer chemoprevention. Amino Acids 33 (2007) 189-195
61. Moon Y.J., Wang X., and Morris M.E. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol In Vitro 20 (2006) 187-210
62. Tamaka T., Makita H., Kawabata K., Mori H., Kakumoto M., Satoh K., et al. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis 18 (1997) 957-965
63. Au A., Li B., Wang W., Roy H., Koehler K., and Birt D. Effects of dietary apigenin on colonic ornithine decarboxylase activity, aberrant crypt foci formation, and tumorigenesis in different experimental models. Nutr Cancer 54 (2006) 243-251
64. Cassidy A. Potential risks and benefits of phytoestrogen-rich diets. Int J Vitam Nutr Res 73 (2003) 120-126
65. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol 3 (2002) 364-373
66. Cotterchio M., Boucher B.A., Manno M., Gallinger S., Okey A., and Harper P. Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J Nutr 136 (2006) 3046-3053
67. Booth C., Hargreaves D.F., Hadfield J.A., McGown A.T., and Potten C.S. Isoflavones inhibit intestinal epithelial cell proliferation and induce apoptosis in vitro. Br J Cancer 80 (1999) 1550-1557
68. Ravindranath M.H., Muthugounder S., Presser N., and Viswanathan S. Anticancer therapeutic potential of soy isoflavone, genistein. Adv Exp Med Biol 546 (2004) 121-165
69. Hawrylewiez E.J., Zapata J.J., and Blair W.H. Soy and experimental cancer: animal studies. J Nutr 125 (1995) 698S-708S
70. Shon Y.H., Park S.D., and Nam K.S. Effective chemopreventive activity of genistein against human breast cancer cells. J Biochem Mol Biol 39 (2006) 448-451
71. Linsalata M., Russo F., Notarnicola M., Guerra V., Cavallini A., Clemente C., and Messa C. Effects of genistein on the polyamine metabolism and cell growth in DLD-1 human colon cancer cells. Nutr Cancer 52 (2005) 83-92
72. Sengottuvelan M., Senthilkurmar R., and Nalini N. Modulatory influence of dietary resveratrol during different phases of 1,2-dimethylhydrazine induced mucosal lipid-peroxidation, antioxidant status and aberrant crypt foci development in rat colon carcinogenesis. Biochim Biophys Acta 1760 (2006) 1175-1183
73. Wolter F., and Stein J. Resveratrol enhances the differentiation induced by butyrate in Caco-2 colon cancer cells. J Nutr 132 (2002) 298-302
74. Schneider Y., Vincent F., Duranton B., Badolo L., Gosse F., Bergmann C., et al. Anti-proliferative effects of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Lett 158 (2000) 85-91
75. Schneider Y., Duranton B., Gosse F., Scheiffer R., Seiler R., and Raul F. Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis. Nutr Cancer 39 (2001) 102-107
76. Wolter F., Turchanova L., and Stein J. Resveratrol-induced modification of polyamine metabolism is accompanied by induction of c-Fos. Carcinogenesis 24 (2003) 469-474
77. Ulrich S., Loitsch S.M., Rau O., Von Knethen A., Brune B., Schubert-Zsilavecz M., and Stein J.M. Peroxisome proliferator-activated receptor gamma as a molecular target of resveratrol-induced modulation of polyamine metabolism. Cancer Res 66 (2006) 7348-7354
78. Wallace H.M., Faser A.V., and Hughes A. A perspective of polyamine metabolism. Biochem J 376 (2003) 1-14
79. Wolter F., Ulrich S., and Stein J. Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in colorectal cancer: key role of polyamines?. J Nutr 134 (2004) 3219-3222
80. Das D., Arber N., and Jankowski J.A. Chemoprevention of colorectal cancer. Digestion 76 (2007) 51-67
81. Lin D.C. Probiotics as functional foods. Nutr Clin Pract 18 (2003) 497-506
82. Wollowski I., Rechkemmer G., and Pool-Zobel B.L. Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr 73 suppl (2001) 451S-455S
83. Reddy B.S. Possible mechanisms by which pro- and prebiotics influence colon carcinogenesis and tumor growth. J Nutr 129 (1999) 1478S-1482S
84. Di Marzio L., Russo F.P., D'Alò S., Biordi L., Ulisse S., Amicosante G., et al. Apoptotic effects of selected strains of lactic acid bacteria on a human T leukaemia cell line are associated with bacterial arginine deiminase and/or sphigomyelinase activities. Nutr Cancer 40 (2001) 185-196
85. Linsalata M., Russo F., Berloco P., Caruso M.L., Di Matteo G., Cifone M.G., et al. The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa. Helicobacter 9 (2004) 165-172
86. Russo F., Orlando A., Linsalata M., Cavallini A., and Messa C. Effects of Lactobacillus rhamnosus GG on the cell growth and polyamine metabolism in HGC-27 human gastric cancer cells. Nutr Cancer 59 (2007) 106-114
87. Singh J., Rivenson A., Tomita M., Shimamura S., Ishibashi N., and Reddy B.S. Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 18 (1997) 833-841
88. Linsalata M., Russo F., Berloco P., Valentini A.M., Caruso M.L., De Simone C., et al. Effects of probiotic bacteria (VSL#3) on the polyamine biosynthesis and cell proliferation of normal colonic mucosa of rats. In Vivo 19 (2005) 989-996